Nokia is set to buy digital health product maker Withings, which had raised almost $34m from backers including Idinvest Partners, for $193m.

The generic pharmaceuticals manufacturer has launched a corporate venturing subsidiary with an initial commitment of $30m.

Wuxi PharmaTech has returned to help fund Hua Medicine's series C round, after previously taking part in its $50m series A and $25m series B rounds.

Bright Lifecare's prescription services spinout has secured $15m in series B funding, following a $6m Intel-backed round last year.

The dyslipidemia treatment developer has filed for a $60m initial public offering that will allow Pfizer, from which it licensed its lead candidate, to exit.